Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.

For information on Biotech 2013-Life Sciences: Capturing Value and other Burrill & Company publications, click here.

Biotech 2011-Life Sciences: Looking Back to See Ahead - PRINT

Burrill & Company's 25th annual report on the biotech industry

Reinventing the Industry

Considered required reading by top executives in the life science industry, this book is an invaluable, one-stop resource to make sense of the changing landscape.
In Looking Back to See Ahead, you will discover:

• How pharmaceutical companies are reinventing themselves to address their pipeline problems and the competition from generics

• New strategies investors are pursuing to improve their returns

• How the convergence of wireless, mobile, and Internet technologies is making personalized medicine a reality

• The global interplay between science, business, regulatory, reimbursement, politics and policy
Comprehensive, unparalleled coverage of key trends makes Looking Back to See Ahead a critical resource for senior executives, as well as business development, sales, investment, legal, economic development, and other professionals who support the industry, to stay competitive in a fast-moving world.

G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for more than 45 years. In 2002, Mr. Burrill was recognized as a biotech investment visionary by Scientific American magazine, and in 2008 he received the BayBio Pantheon DiNA lifetime achievement award for his worldwide biotech leadership. He is an advisor to University of Illinois Institute for Genomic Biology, University of Wisconsin College of Agricultural and Life Sciences, University of California, Davis, University of Minnesota College of Biological Sciences, and the Duke University Institute for Genome Science and Policy, and is an adjunct professor at University of California, San Francisco. He is the founder and CEO of Burrill & Company, a global financial services firm exclusively serving the life sciences industry.

Click here to view the table of contents and a list of charts and graphs.

Please note that we will only refund orders returned in their original packaging within three weeks of the order.  All electronic sales are final.


Add to cart$250.00